Hofseth BioCare ASA (FRA:HBQ)

Market Cap	66.79M
Revenue (ttm)	21.25M
Net Income (ttm)	-11.12M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	375
Open	0.1045
Previous Close	0.1075
Day's Range	0.1045 - 0.1090
52-Week Range	0.0878 - 0.3050
Beta	n/a
RSI	43.76
Earnings Date	Feb 13, 2026

About Hofseth BioCare ASA

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2000
• Employees: 78
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HBQ

Financial Performance

In 2024, Hofseth BioCare ASA's revenue was 265.54 million, an increase of 21.52% compared to the previous year's 218.51 million. Losses were -125.30 million, 17.4% more than in 2023.

Financial numbers in NOK